Sai Life Sciences, a full-service contract research, development and manufacturing organisation (CRO-CDMO), has announced the opening of a new biology facility at its integrated R&D campus in Hyderabad.

The new state-of-the-art facility houses expanded in vitro and in vivo biology services, DMPK, toxicology and a vivarium. The facility augments both, its capabilities and capacity, to deploy cutting-edge platforms and technologies for accelerating integrated drug discovery programmes.

The new facility culminates the company's journey of unifying its discovery, early and late phase development and clinical supply capabilities in a single 13-acre campus housing over 1000 scientists, delivering integrated value at scale.

Krishna Kanumuri, CEO and MD, Sai Life Sciences, said, "The new facility marks the culmination of a journey we began two years ago, of creating differentiated value for our discovery clients through an integrated delivery model across Boston and Hyderabad. By bringing the best of talent, technology, complementary services and efficiency we are confident of bringing unique value to our clients and are keen to take on integrated discovery mandates, at scale."